Page last updated: 2024-08-23

atracurium and Muscular Weakness

atracurium has been researched along with Muscular Weakness in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arvieux, CC; Gioux, M; Giroux-Metges, MA; Gueret, G; Morel, J; Pennec, JP; Rannou, F; Rossignol, B; Talarmin, H1
Blobner, M; Fink, H; Frick, CG; Helming, M; Martyn, JA1
Devlin, JW; Garpestad, E; Hill, NS1
Kopman, AF; Neuman, GG; Ng, J; Zank, LM1
Fry, RA; Yousif, HY1
David, WS; Davies, SF; Fluegel, WL; Iber, C; Leatherman, JW1
Coakley, J1

Reviews

1 review(s) available for atracurium and Muscular Weakness

ArticleYear
Should ICU patients receive muscle relaxants?
    Schweizerische medizinische Wochenschrift, 1996, Sep-28, Volume: 126, Issue:39

    Topics: Atracurium; Critical Care; Humans; Intensive Care Units; Muscle Weakness; Neuromuscular Blocking Agents; Neuromuscular Nondepolarizing Agents; Vecuronium Bromide

1996

Trials

1 trial(s) available for atracurium and Muscular Weakness

ArticleYear
Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: should quantitative assessment of neuromuscular function be mandatory?
    Anesthesia and analgesia, 2004, Volume: 98, Issue:1

    Topics: Adolescent; Adult; Aged; Androstanols; Anesthesia Recovery Period; Atracurium; Cholinesterase Inhibitors; Electric Stimulation; Female; Glycopyrrolate; Humans; Male; Middle Aged; Muscarinic Antagonists; Muscle Weakness; Neostigmine; Neuromuscular Nondepolarizing Agents; Neurons; Pain Measurement; Postoperative Complications; Rocuronium; Synaptic Transmission

2004

Other Studies

5 other study(ies) available for atracurium and Muscular Weakness

ArticleYear
Effects of chronic sepsis on contractile properties of fast twitch muscle in an experimental model of critical illness neuromyopathy in the rat.
    Critical care medicine, 2008, Volume: 36, Issue:6

    Topics: Animals; Atracurium; Chronic Disease; Disease Models, Animal; Female; Gene Expression; Muscle Contraction; Muscle Fibers, Fast-Twitch; Muscle Strength; Muscle Weakness; Polyneuropathies; Rats; Rats, Wistar; Receptors, Cholinergic; RNA, Messenger; Ryanodine Receptor Calcium Release Channel; Systemic Inflammatory Response Syndrome

2008
Continuous administration of pyridostigmine improves immobilization-induced neuromuscular weakness.
    Critical care medicine, 2010, Volume: 38, Issue:3

    Topics: Animals; Atracurium; Cholinesterase Inhibitors; Disease Models, Animal; Hindlimb; Immobilization; Infusion Pumps; Infusions, Subcutaneous; Male; Muscle Contraction; Muscle Strength; Muscle Weakness; Muscular Atrophy; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pyridostigmine Bromide; Rats; Rats, Sprague-Dawley; Receptors, Cholinergic

2010
Neuromuscular blockers and ARDS.
    The New England journal of medicine, 2010, 12-23, Volume: 363, Issue:26

    Topics: Atracurium; Double-Blind Method; Humans; Muscle Weakness; Neuromuscular Blocking Agents; Respiration, Artificial; Respiratory Distress Syndrome; Survival Rate; Time Factors

2010
Anaesthesia for abdominal aneurysm repair in a patient with Guillain-Barré Syndrome.
    Anaesthesia and intensive care, 2007, Volume: 35, Issue:2

    Topics: Abdominal Pain; Aged; Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; Aortic Aneurysm, Abdominal; Atracurium; Desflurane; Fentanyl; Follow-Up Studies; Gait Disorders, Neurologic; Guillain-Barre Syndrome; Humans; Incidental Findings; Isoflurane; Male; Monitoring, Intraoperative; Muscle Weakness; Neuromuscular Nondepolarizing Agents; Piperidines; Propofol; Radiography, Abdominal; Remifentanil; Tomography, X-Ray Computed; Treatment Outcome

2007
Muscle weakness in mechanically ventilated patients with severe asthma.
    American journal of respiratory and critical care medicine, 1996, Volume: 153, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Aged; Albuterol; Asthma; Atracurium; Bronchodilator Agents; Cohort Studies; Female; Glucocorticoids; Humans; Incidence; Male; Methylprednisolone; Middle Aged; Muscle Weakness; Muscular Diseases; Neuromuscular Nondepolarizing Agents; Pancuronium; Respiration, Artificial; Retrospective Studies; Risk Factors; Time Factors; Vecuronium Bromide

1996